The global gene synthesis market is increasing at a significant CAGR during the forecast period. The major factors that are assisting in the growth of the market include rising research and development in the field of genomics coupled with next-generation DNA sequencing process. In recent days, the need for genetic analysis has increased substantially because technology has produced reliable and accurate results. Gene synthesis is defined as a flexible and robust molecule engineering tool utilized in synthetic biology that is primarily used for chemical DNA synthesis. Since the first artificial gene synthesis was developed by Gobind Khorana’s group in 1970 there have been numerous developments and updates in the synthesis such as sequencing, automation, and amplification.
To learn more about this report request a free sample copy @
Additionally, there has been a rise in funding from the government towards further researches in genomics which has significantly driven the growth of the gene synthesis market till now and is expected to drive the market in the future as well. Furthermore, increasing demand for personalized medicine is another major factor, as it has gained popularity for the last couple of years owing to its benefits such as according to a molecular basis of the disease, customized therapies can be provided, individual patients. Hence contributing to the growth of the gene synthesis market. Additionally, gene synthesis also finds application in the treatment of bacterial and genetic disorders in molecular systems. Commercial availability of genetic tests has increased that can identify genetic variations and predict how a person will react to certain medications, this is further aiding in the growth of the market.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/gene-synthesis-market
Moreover, there is a rise in the adoption of the latest technologies including healthcare technology, connected devices, big data analytics, and artificial intelligence which is generating a myriad of health-related data and insights. This enables health care providers to provide better and quicker diagnoses and to make better-informed decisions on treatments. Additionally, numerous organizations have been established owing to collaboration and merger between various research organizations and universities to develop life-saving treatments for patients. For instance, the Trinity Genome Sequencing Laboratory situated inside Trinity Translational Medicine Institute in Dublin, Ireland. This laboratory has developed a platform maned “Illumina MiSeq” which is primarily developed for performing the ultra-high throughput genomics research. These institutes are receiving funds from the various governments as well as private organizations further augmenting the growth of the market.
The key market players dominating the global gene synthesis market include ATDBio, ATUM, Bioneer Corporation, BioCat, Blue Heron Biotech, Biomatik, Epoch Life Science, GENEWIZ, Eurofins Genomics, and Integrated DNA Technologies. The companies are focused on developing advanced gene synthesis technology to stay competitive in the market. Geographical expansion, merger & acquisition, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopted by major market players.
Global Gene Synthesis Market – Segment
By Method
- Oligonucleotide Synthesis
- Gene Assembly
By End-User
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
Global Gene Synthesis Market – Regional
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Agilent Technologies Inc.
- Aldevron LLC
- Bio Basic Inc.
- BioCat Gmbh
- Biomatik
- Blue Heron Biotech, LLC
- Custom Array, Inc.
- 0 Inc. (Atum)
- Eurofins Genomics
- Evonetix, Ltd.
- Merck KGaA (Sigma Aldrich)
- Thermo Fisher Scientific Inc. (GeneArt)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
